Trial Profile
Comparative Feasibility and Efficacy of a Five Compartment Technique Using 0.25% Bupivacaine vs a Mixture of 0.25% Bupivacaine and 1.3 % Liposomal Bupivacaine in Patients Undergoing Tka; a Single Blinded Randomized Controlled Study
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 21 Mar 2020
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Anaesthesia
- Focus Therapeutic Use
- 07 Jun 2019 Status changed from not yet recruiting to discontinued.
- 10 Oct 2017 New trial record